Details for New Drug Application (NDA): 021764
✉ Email this page to a colleague
NDA 021764 describes QOLIANA, which is a drug marketed by Sandoz and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the QOLIANA profile page.
The generic ingredient in QOLIANA is brimonidine tartrate. There are eleven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate profile page.
The generic ingredient in QOLIANA is brimonidine tartrate. There are eleven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate profile page.
Summary for 021764
| Tradename: | QOLIANA |
| Applicant: | Sandoz |
| Ingredient: | brimonidine tartrate |
| Patents: | 1 |
Pharmacology for NDA: 021764
| Mechanism of Action | Adrenergic alpha-Agonists |
Medical Subject Heading (MeSH) Categories for 021764
Suppliers and Packaging for NDA: 021764
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| QOLIANA | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 021764 | NDA | Sandoz Inc | 61314-144 | 61314-144-05 | 5 mL in 1 BOTTLE (61314-144-05) |
| QOLIANA | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 021764 | NDA | Sandoz Inc | 61314-144 | 61314-144-10 | 10 mL in 1 BOTTLE (61314-144-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.15% | ||||
| Approval Date: | May 22, 2006 | TE: | AT | RLD: | Yes | ||||
| Patent: | ⤷ Try a Trial | Patent Expiration: | Aug 19, 2025 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Complete Access Available with Subscription
